Design of Aminopeptidase N Inhibitors as Anti-cancer Agents

被引:87
|
作者
Amin, Sk Abdul [1 ]
Adhikari, Nilanjan [1 ]
Jha, Tarun [1 ]
机构
[1] Jadavpur Univ, Dept Pharmaceut Technol, Div Med & Pharmaceut Chem, Nat Sci Lab, POB 17020, Kolkata 700032, W Bengal, India
关键词
HEPATOCELLULAR-CARCINOMA CELLS; STREPTOMYCES-AZUREUS MH663-2F6; LEUCINE UREIDO DERIVATIVES; 1ST HIGHLY POTENT; MATRIX-METALLOPROTEINASE; CLINICAL-SIGNIFICANCE; SELECTIVE INHIBITORS; ACID-DERIVATIVES; PYRROLIDINE DERIVATIVES; BIOLOGICAL EVALUATION;
D O I
10.1021/acs.jmedchem.7b00782
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aminopeptidase N (APN) is an important metalloenzyme. It regulates multivariate cellular functions by different mechanisms such as enzymatic cleavage of peptides. This may play a role in endocytosis and regulate signal transduction. APN, a member of the MI zinc metallopeptidase family, plays crucial roles in a variety of functions such as migration and invasion, and angiogenesis and metastasis of tumor cells. Therefore, APN inhibitors may be useful for the treatment of cancer. In this Perspective, structure activity relationships of APN inhibitors are discussed to get an idea of possible lead candidates. APN inhibitors should possess an aryl hydrophobic function along with a zinc binding group attached to the hydrophobic group(s) to achieve high potency. This and other design aspects of APN inhibitors are discussed in this Perspective.
引用
收藏
页码:6468 / 6490
页数:23
相关论文
共 50 条
  • [1] Proteasome inhibitors as anti-cancer agents
    Murray, RZ
    Norbury, C
    ANTI-CANCER DRUGS, 2000, 11 (06) : 407 - 417
  • [2] Sialyltransferase Inhibitors as Potential Anti-Cancer Agents
    Skropeta, Danielle
    Dobie, Christopher
    Montgomery, Andrew P.
    Steele, Harrison
    Szabo, Remi
    Yu, Haibo
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2021, 74 (11) : 758 - 766
  • [3] Aminopeptidase N (APN/CD13) as a Target for Anti-Cancer Agent Design
    Zhang, Xiaopan
    Xu, Wenfang
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (27) : 2850 - 2865
  • [4] Prospects of Topoisomerase Inhibitors as Promising Anti-Cancer Agents
    Yakkala, Prasanna Anjaneyulu
    Penumallu, Naveen Reddy
    Shafi, Syed
    Kamal, Ahmed
    PHARMACEUTICALS, 2023, 16 (10)
  • [5] Hedgehog Signaling Inhibitors as Anti-Cancer Agents in Osteosarcoma
    Ram Kumar, Ram Mohan
    Fuchs, Bruno
    CANCERS, 2015, 7 (02): : 784 - 794
  • [6] Mitotic kinesin inhibitors as novel anti-cancer agents
    Wood, KW
    Bergnes, G
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39, 2004, 39 : 173 - 183
  • [7] mTOR inhibitors: A novel class of anti-cancer agents
    Haris Riaz
    Talha Riaz
    Syed A Hussain
    Infectious Agents and Cancer, 7
  • [8] mTOR inhibitors: A novel class of anti-cancer agents
    Riaz, Haris
    Riaz, Talha
    Hussain, Syed A.
    INFECTIOUS AGENTS AND CANCER, 2012, 7
  • [9] Role of the Heterocycles to Design Anti-Cancer Agents
    Banerjee, Bubun
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (19) : 3194 - 3195
  • [10] Novel N-hydroxybenzamide histone deacetylase inhibitors as potential anti-cancer agents
    Jiao, Jie
    Fang, Hao
    Xu, Wenfang
    DRUG DISCOVERIES AND THERAPEUTICS, 2008, 2 (04): : 211 - 215